Recent Post
ImmunityBio (NASDAQ: IBRX) Advances in Oncology: Gearing Up for ANKTIVA’s Commercial...
In a major stride towards addressing bladder cancer, ImmunityBio, Inc. (NASDAQ: IBRX) has recently completed the manufacturing of a drug substance that...
